1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of ovarian cancer screening in women with BRCA mutations
    Meeting Abstract

    Lewin, S. N.; Kemel, Y.; Kosarin, K.; Hansen, J.; Robson, M. E.; Offit, K.; Barakat, R. R.; Kauff, N. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Meeting Abstract

    Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer
    Meeting Abstract

    Comen, E. A.; Davids, M.; Kirchhoff, T.; Balistreri, L.; Hansen, J.; Kosarin, K.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save
  • Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007
    Journal Article

    Schwartz, G. F.; Hughes, K. S.; Lynch, H. T.; Fabian, C. J.; Fentiman, I. S.; Robson, M. E.; Domchek, S. M.; Hartmann, L. C.; Holland, R.; Winchester, D. J.; more...
    Cancer (2008)

    Fulltext@MSK | Save
  • Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study
    Journal Article

    Kauff, N. D.; Domchek, S. M.; Friebel, T. M.; Robson, M. E.; Lee, J.; Garber, J. E.; Isaacs, C.; Evans, D. G.; Lynch, H.; Eeles, R. A.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Impact of risk-reducing oophorectomy on quality of life in women at risk for ovarian cancer
    Meeting Abstract

    McArthur, H. L.; Hensley, M.; Brown, C. L.; Chi, D. S.; Offit, K.; Hurley, K.; Li, Y.; Gemignani, M. L.; Robson, M. E.; Barakat, R. R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Toward individualized risk prediction: The clinical benefit of risk reduction mastectomy and oophorectomy in BRCA carriers with breast cancer
    Meeting Abstract

    Burke, H. B.; Hoang, A.; Metcalfe, K.; Culver, J. O.; MacDonald, D. J.; Grant, M.; Thornton, A.; Robson, M.; Narod, S.; Weitzel, J. N.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save